These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 25563848)

  • 1. Testosterone therapy and prostate cancer--safety concerns are well founded.
    Klotz L
    Nat Rev Urol; 2015 Jan; 12(1):48-54. PubMed ID: 25563848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer risk in testosterone-treated men.
    Raynaud JP
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):261-6. PubMed ID: 17113983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
    Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone use in women: how safe is it?
    Tan RS; Teoh SH
    Curr Drug Saf; 2013 Apr; 8(2):120-7. PubMed ID: 23713539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring androgen replacement therapy: testosterone and prostate safety.
    Morales A
    J Endocrinol Invest; 2005; 28(3 Suppl):122-7. PubMed ID: 16042371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone therapy in women with androgen deficiency: Its time has come.
    Guay A; Traish A
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1116-26. PubMed ID: 20872314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone therapy: has overuse undermined use?
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):157. PubMed ID: 29475492
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of androgen supplementation therapy on the prostate.
    Kaufman JM
    Aging Male; 2003 Sep; 6(3):166-74. PubMed ID: 14628497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editor's Comment--How Dangerous is Testosterone Supplementation?
    Jenkins LC; Mulhall JP
    Int Braz J Urol; 2015; 41(2):195-8. PubMed ID: 26005958
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen replacement therapy and prostate safety.
    Morales A
    Eur Urol; 2002 Feb; 41(2):113-20. PubMed ID: 12074396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Androgens and cardiovascular risk: A series of case report in the French and Canadian pharmacovigilance databases].
    Rochoy M; Thomas R; Béné J; Deleplanque D; Vantyghem MC; Gautier S; Deplanque D;
    Prog Urol; 2018 May; 28(6):315-321. PubMed ID: 29650456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone replacement therapy and prostate risks: where's the beef?
    Morgentaler A
    Can J Urol; 2006 Feb; 13 Suppl 1():40-3. PubMed ID: 16526980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen deficiency in older men: indications, advantages, and pitfalls of testosterone replacement therapy.
    McGill JJ; Shoskes DA; Sabanegh ES
    Cleve Clin J Med; 2012 Nov; 79(11):797-806. PubMed ID: 23125330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy and prostate cancer: a word of caution.
    Brand TC; Canby-Hagino E; Thompson IM
    Curr Urol Rep; 2007 May; 8(3):185-9. PubMed ID: 17459266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy.
    Xie T; Song XL; Wang C; Yu YZ; Wang JQ; Chen ZS; Zhao SC
    Drug Discov Today; 2021 May; 26(5):1293-1301. PubMed ID: 33561465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes.
    Kaplan AL; Hu JC
    Urology; 2013 Aug; 82(2):321-6. PubMed ID: 23706552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer in Klinefelter syndrome during hormonal replacement therapy.
    Hwang JJ; Dharmawardana PG; Uchio EM; Wynberg J; Phillips JL
    Urology; 2003 Nov; 62(5):941. PubMed ID: 14624928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological and clinical advances of androgen receptor function in age-related diseases and cancer [Review].
    Takayama KI
    Endocr J; 2017 Oct; 64(10):933-946. PubMed ID: 28824023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Exposure to Testosterone Therapy and the Risk of High Grade Prostate Cancer.
    Baillargeon J; Kuo YF; Fang X; Shahinian VB
    J Urol; 2015 Dec; 194(6):1612-6. PubMed ID: 26066403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.